Science and Innovation Stories

SCIENCE & INNOVATION 09.17.2024

ESMO 2024: Targeting the Root Cause of Cancers

Three ways Amgen is leveraging emerging biomarkers and new modalities in oncology.

Read more

All Stories <i class="fa fa-angle-down"></i><i class="fa fa-angle-up"></i>

SCIENCE & INNOVATION 09.17.2024
ESMO 2024: Targeting the Root Cause of Cancers
SCIENCE & INNOVATION 06.20.2024
Amgen Continues to Propel BiTE® Technology Innovation
SCIENCE & INNOVATION 05.22.2024
From the Office to the Lab, Amgen Uses AI Tools to Unlock Innovation
SCIENCE & INNOVATION 05.20.2024
At Milken Global Conference, Bradway Calls for Protecting U.S. Policy Ecosystem That Fosters Innovation
SCIENCE & INNOVATION 04.24.2024
How Amgen’s Real-World Evidence Is Changing The Future of Patient Care in Psoriatic Disease
SCIENCE & INNOVATION 04.16.2024
Navigating the Landscape of Precision Medicine in Gastric Cancer: FGFR2b Protein Overexpression as an Emerging Biomarker
SCIENCE & INNOVATION 04.04.2024
How the LATTICE™ Consortium Is Igniting Action and Innovation in Cardiovascular Care
SCIENCE & INNOVATION 02.26.2024
Amgen Goes “OH-IO” with Opening of Newest Manufacturing Facility
SCIENCE & INNOVATION 01.08.2024
Amgen Staff Helping Shatter Scientist Stereotypes
SCIENCE & INNOVATION 12.08.2023
ASH23: Advancements for Tough-to-Treat Blood Cancers
SCIENCE & INNOVATION 11.28.2023
Any Target, Every Time
SCIENCE & INNOVATION 10.19.2023
Three Things to Look Forward to at #ESMO23
Load more